Calyxt Inc (CLXT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: AGRICULTURAL CHEMICALS

2800 MOUNT RIDGE ROAD ROSEVILLE, MN 55113

Calyxt, Inc. provides agricultural biotechnology services. The Company researches and develops seeds and food ingredients for agricultural, feed, and food applications, as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt markets its products in the United States.

Data as of 2020-08-09
Market Cap185.5 Million Shares Outstanding33.184 Million Avg 30-day Volume85.437 Thousand
P/E Ratio Dividend Yield EPS-1.36
Price/Sales16.252 Price cash flow ratio Price free cash flow ratio-4.2
Book Value1.31 Price to Tangible Book4.26 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.173341
BETA2.32766 52-week High/Low8.27 / 2.4 Stddev0.273537
View SEC Filings from CLXT instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 54 16 (1.05%)
Aggregate 13F shares on 03/31/2020: 7.906 Million 5.535 Million
Aggregate 13F shares on 12/31/2019: 8.072 Million 5.358 Million
Percent change: -2.06% 3.30%
Funds creating new positions: 8 2
Funds Adding to an existing position: 17 7
Funds closing out their position: 5
Funds reducing their position: 18 5
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CLXT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLXT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

306 total shares from 2 transactions

Open Market Sells (S)

10.6 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KOZICZ-STANKIEWICZ ANNA EWA

  • Director
3,655 2020-08-04 3

VOYTAS DANIEL F CHIEF SCIENCE OFFICER

  • Officer
7,539 2020-08-04 1

DUMONT PHILIPPE

  • Director
1,762 2020-08-04 3

RIBEILL YVES J

  • Director
30,030 2020-08-04 2

JONATHAN FASSBERG

  • Director
2,940 2020-08-04 1

NEUGENT CHRISTOPHER J

  • Director
2,940 2020-08-04 1

BLOME JAMES CHIEF EXECUTIVE OFFICER

  • Officer
194,562 2020-08-04 3

KOSCHAK WILLIAM CHIEF FINANCIAL OFFICER

  • Officer
0 2020-08-04 1

NELSON KIMBERLY K.

  • Director
0 2020-08-04 1

FRIMERMAN DEBRA H GENERAL COUNSEL

  • Officer
0 2020-08-04 1

FREY TRAVIS CHIEF TECHNOLOGY OFFICER

  • Officer
2,300 2020-08-04 11

ARTHAUD LAURENT

  • Director
0 2020-07-06 1

CHOULIKA ANDRE

  • Director
130,815 2020-07-01 2

SALURI JOSEPH

  • Director
0 2020-06-19 0

SAHOO MANOJ CHIEF COMMERCIAL OFFICER

  • Officer
65,323 2019-07-01 0

GODARD ALAIN

  • Director
33,320 2018-06-21 0

DUTANG ERIC CHIEF FINANCIAL OFFICER

  • Officer
94,530 2018-06-21 0

ARBADJI MICHEL DIRECTOR OF BUSINESS DEVELOPME

  • Officer
24,990 2018-06-20 0

CELLECTIS S.A.

  • 10% Owner
22,713,175 2018-06-15 0

TRIPODI FEDERICO A. CHIEF EXECUTIVE OFFICER

  • Officer
181,300 2018-06-15 0

CORKAL BRYAN W.J. CHIEF FINANCIAL OFFICER

  • Officer
73,807 2018-06-15 0

BOWERS GLENN R VICE PRESIDENT OF BREEDING

  • Officer
8,617 2018-06-15 0

ZHANG FENG CHIEF OPERATIONS OFFICER

  • Officer
29,400 2017-07-20 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

RIBEILL YVES J - Director

2020-08-04 A 25,000 a 25,000 30,030.00 direct

KOSCHAK WILLIAM - Officer CHIEF FINANCIAL OFFICER

2020-08-04 A 110,000 a 110,000 0.00 direct

NELSON KIMBERLY K. - Director

2020-08-04 A 7,500 a 7,500 0.00 direct

DUMONT PHILIPPE - Director

2020-08-04 A 5,000 a 5,000 1,762.00 direct

BLOME JAMES - Officer CHIEF EXECUTIVE OFFICER

2020-08-04 A 175,000 a 175,000 194,562.00 direct

KOZICZ-STANKIEWICZ ANNA EWA - Director

2020-08-04 A 5,000 a 5,000 3,655.00 direct

NEUGENT CHRISTOPHER J - Director

2020-08-04 A 7,500 a 7,500 2,940.00 direct

FRIMERMAN DEBRA H - Officer GENERAL COUNSEL

2020-08-04 A 80,000 a 80,000 0.00 direct

FREY TRAVIS - Officer CHIEF TECHNOLOGY OFFICER

2020-08-04 A 80,000 a 80,000 2,300.00 direct

VOYTAS DANIEL F - Officer CHIEF SCIENCE OFFICER

2020-08-04 A 65,000 a 65,000 7,539.00 direct

JONATHAN FASSBERG - Director

2020-08-04 A 5,000 a 5,000 2,940.00 direct

FREY TRAVIS - Officer CHIEF TECHNOLOGY OFFICER

2020-08-03 P 150 $4.36 a 2,300 2,300.00 direct

FREY TRAVIS - Officer CHIEF TECHNOLOGY OFFICER

2020-07-01 P 156 $5.04 a 2,150 2,150.00 direct

BLOME JAMES - Officer CHIEF EXECUTIVE OFFICER

2020-07-01 S 3,495 $4.65 d 194,562 194,562.00 direct

CHOULIKA ANDRE - Director

2020-07-01 S 4,228 $4.65 d 130,815 130,815.00 direct

BLOME JAMES - Officer CHIEF EXECUTIVE OFFICER

2020-06-29 S 2,902 $5.01 d 198,057 194,562.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments